A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.

J N Ingle; P A Johnson; V J Suman; J B Gerstner; J A Mailliard; J K Camoriano; D H Gesme; C L Loprinzi; A K Hatfield; L C Hartmann

doi:10.1002/(sici)1097-0142(19970715)80:2<218::aid-cncr8>3.0.co;2-p

A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.

Identifier:nobleid.org/w1/20260515/66A7FDCE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/66A7FDCE.svg?ark=w1%2F20260515%2F66A7FDCE)](https://nobleid.org/work/w1/20260515/66A7FDCE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.

Identifier:nobleid.org/w1/20260515/66A7FDCE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/66A7FDCE.svg?ark=w1%2F20260515%2F66A7FDCE)](https://nobleid.org/work/w1/20260515/66A7FDCE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work